Search
for
Sort by
Research 30 of 1000+
- Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
- Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism
- Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial
- Pharmacology and Potential Use of Cyproterone Acetate
- A Prospective Randomized Trial Comparing Low Dose Flutamide, Finasteride, Ketoconazole, and Cyproterone Acetate-Estrogen Regimens in the Treatment of Hirsutism
- Cyproterone acetate for severe hirsutism:results of a double‐blind dose‐ranging study*
- The significance of CYP11A1 expression in skin physiology and pathology
- Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study
- The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in women
- Cyproterone acetate for hirsutism
- The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea.
- Comparison of Sequential Cyproterone Acetate/Estrogen Versus Spironolactone/Oral Contraceptive in the Treatment of Hirsutism
- Androgen metabolism in hirsute patients treated with cyproterone acetate
- Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study
- A Keratinocyte-specific Epoxygenase, CYP2B12, Metabolizes Arachidonic Acid with Unusual Selectivity, Producing a Single Major Epoxyeicosatrienoic Acid
- The Evaluation of the Role of Androgens in Hirsutism and the Use of a New Anti-androgen “Cyproterone Acetate” for Therapy
- Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism
- Liarozole—a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: a review
- Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism
- Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission
- A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive.
- 11 Treatment of hirsutism and acne with cyproterone acetate
- Treatment of hirsutism and acne in women with two combinations of cyproterone acetate and ethinylestradiol.
- Cyproterone acetate-loaded nanostructured lipid carriers: effect of particle size on skin penetration and follicular targeting
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- Finasteride versus cyproterone acetate-estrogen regimens in the treatment of hirsutism
- Treatment of Hirsutism, Acne and Alopecia with Cyproterone Acetate
- Consecutive Cyproterone Acetate and Estradiol Treatment in Late-Pubertal Transgender Female Adolescents